US Patent Issued to KALIA HEALTH on Oct. 7 for "Preeclampsia screening device and methods measuring activin and/or inhibin A" (American, Ugandan Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,436,155, issued on Oct. 7, was assigned to KALIA HEALTH INC. (Chapel Hill, N.C.).

"Preeclampsia screening device and methods measuring activin and/or inhibin A" was invented by Denali K. Dahl (Chapel Hill, N.C.), Brian Matovu (Kampala, Uganda) and Zoe Sekyonda (Cleveland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are diagnostic and/or screening tests, assays and devices for preeclampsia (PE). The diagnostic and/or screening tests, assays and devices include test antibodies for activin A and/or inhibin A. The PE diagnostic and/or screening tests, assays and devices are capable of detecting activin A and/or inhibin A in a sample at a concentra...